Amir Shlomai
- Epidemiology top 1%
- Hepatology top 0.5%
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 2%
- Surgery top 10%
- Co-authors
- Charles M. RiceYosef ShaulYpe P. de JongZamir HalpernVyas RamananNoam PelegSangeeta N. BhatiaRan Oren
- Topics
- Liver Disease Diagnosis and Treatment (32 papers)Hepatitis B Virus Studies (25 papers)Hepatitis C virus research (21 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Amir Shlomai
72 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Epidemiology 2.4k
- Hepatology 1.4k
- Molecular Biology 1.1k
- Endocrinology, Diabetes and Metabolism 615
- Surgery 477
Countries citing papers authored by Amir Shlomai
This map shows the geographic impact of Amir Shlomai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Shlomai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Shlomai more than expected).
Fields of papers citing papers by Amir Shlomai
This network shows the impact of papers produced by Amir Shlomai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Shlomai. The network helps show where Amir Shlomai may publish in the future.
Co-authorship network of co-authors of Amir Shlomai
This figure shows the co-authorship network connecting the top 25 collaborators of Amir Shlomai. A scholar is included among the top collaborators of Amir Shlomai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Shlomai. Amir Shlomai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 7 | |
| 3 | 104 | |
| 4 | Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysisbreakdown → | 681 |
| 5 | 28 | |
| 6 | 5 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | 39 | |
| 10 | 37 | |
| 11 | 5 | |
| 12 | 60 | |
| 13 | 65 | |
| 14 | CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus | 7 |
| 15 | 31 | |
| 16 | 139 | |
| 17 | 30 | |
| 18 | 73 | |
| 19 | 8 | |
| 20 | 36 |
About Amir Shlomai
Amir Shlomai is a scholar working on Hepatology, Transplantation and Epidemiology, having authored 74 papers that have together received 3.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis B Virus Studies (25 papers) and Hepatitis C virus research (21 papers). The work is most often cited by research in Hepatology (1.4k citations), Epidemiology (2.4k citations) and Endocrinology, Diabetes and Metabolism (615 citations). Amir Shlomai has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Charles M. Rice, Yosef Shaul, Ype P. de Jong, Zamir Halpern, Vyas Ramanan, Noam Peleg, Sangeeta N. Bhatia, Ran Oren, Ankit Bhatta and Sigal Fishman. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.